Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea

Objective Previous studies show that arthralgia is the most common symptom experienced by Ebola virus disease (EVD) survivors. Nevertheless, specific analyses of rheumatological sequelea are still lacking. Methods The Postebogui study is a prospective, multicentre cohort aiming to evaluate the long-term outcomes of EVD survivors infected during the 2014-15 outbreak in Guinea. Of the 216 participants enrolled in the study in October 2015, 44 patients with arthralgia/myalgia underwent a physical examination by a rheumatologist (the Eborheum cohort). Data were collected using a standardized questionnaire. Results In the Eborheum cohort, 61% of patients were female, the median age was 31.1 years, and the median time from Ebola Treatment Centre discharge was 8.8 months. Pain manifestation started after Ebola infection in all but one patient. Patients had mainly both mechanical and inflammatory pain (45%) and low back pain (77%). All patients reported pain in at least one peripheral joint. Pain in large joints was more frequently reported than in small joints (73 vs 41%). Oligo- and polyarticular presentations were similar, with symmetrical pain distribution. Furthermore, 36 patients had at least one painful 18-tender point count, most of whom reported extensive pain (n = 19) and symmetrical distribution (91%). Diagnoses were mainly non-specific musculoskeletal disorders (59%) and mechanical back pain (52%). No polyarthritis was observed. We found a higher percentage of depressed patients compared with the remaining Postebogui group (42 vs 11%; P < 0.001). Conclusion Results from the study come from the first complete rheumatological examination of a cohort of EVD survivors, nearly 9 months after Ebola Treatment Centre discharge. Importantly, we found that patients with arthralgia/myalgia included in the Eborheum cohort were more likely to experience depression than survivors not reporting these symptoms, highlighting the impact of pain symptoms among survivors.

[1]  L. Kaiser,et al.  Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  R. Fowler,et al.  Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. , 2016, The Lancet. Infectious diseases.

[3]  A. Qureshi,et al.  Study of Ebola Virus Disease Survivors in Guinea. , 2015, Clinical Infectious Diseases.

[4]  G. Olinger,et al.  Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. , 2015, Lancet. Infectious Diseases (Print).

[5]  Z. Yoti,et al.  Epidemiology and risk factors for Ebola virus disease in Sierra Leone-23 May 2014 to 31 January 2015. , 2015, Clinical Infectious Diseases.

[6]  Stephan Günther,et al.  Emergence of Zaire Ebola virus disease in Guinea. , 2014, The New England journal of medicine.

[7]  D. Zoutman,et al.  Chikungunya-related arthritis: case report and review of the literature. , 2013, Seminars in arthritis and rheumatism.

[8]  Y. Shoenfeld,et al.  Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. , 2006, Journal of autoimmunity.

[9]  J Bertolli,et al.  Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.

[10]  P. Rollin,et al.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. , 1999, The Journal of infectious diseases.

[11]  D. Isenberg,et al.  Standardising joint assessment in rheumatoid arthritis , 1996, Clinical Rheumatology.

[12]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.